From The Hill
Former Rep. Mimi Walters argues that Washington must prioritize domestic biomedical research and stricter regulatory oversight to counter China’s rising influence and protect American patient safety.
From The Hill
Former Rep. Mimi Walters argues that Washington must prioritize domestic biomedical research and stricter regulatory oversight to counter China’s rising influence and protect American patient safety.
Leave a Reply